IP Library › Granted Patent US 12,364,663
Granted Patent B2
US 12,364,663 · App. 17/639,600 · Granted Jul 22, 2025

Method and equipment for fractionation of granules for use in pharmaceutical compositions

Inventors: Thomas Vilhelmsen (Solroed Strand, DK); Carsten Hoeeg-Moeller (Maaloev, DK); Martin Nobert Soerensen (Koebenhavn, DK); Mette Hoeg Gaunoe (Holbaek, DK)
Assignee: Novo Nordisk A/S
A61K9/1682A61K31/609B07B1/38B07B13/16B07B2230/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,364,663
App. No.
17/639,600
Granted
Jul 22, 2025
Kind
B2
Abstract

A sieve guide assembly and a method of fractionation using a sieve guide assembly comprising a circular sieve screen ( 190 ) and a sieve guide 310 mountable in a fractionating device, wherein the fractionating device comprises a drive adapted for: (i) in combination with a sieve screen without a sieve guide, inducing a lateral flow of granules defining lateral streamlines 31 a. 1. 31 b. 1, 31 c. 1, 31 d. 1 and an orbital flow defining orbital streamlines 31 a. 2. 31 b. 2, 31 c. 2, 31 d. 2, 31 d. 3 on the sieve screen ( 190 ), and (ii) in combination with the sieve guide assembly, inducing a guided lateral flow of granules defining guided lateral streamlines ( 331.3 ) and a central guided orbital flow defining central orbital streamlines ( 331.2 ) on the sieve screen ( 190 ), whereby the sieve guide assembly is adapted to provide a uniform, controlled and effective exposure of the granules to the sieve screen.

Claims (51)

1. A sieve guide assembly a circular sieve screen and a sieve guide,

wherein the sieve guide is fixedly attached to the circular sieve screen;

wherein the circular sieve guide comprises:

(a) a circular guide portion adapted to guide a central guided orbital flow, wherein the central guided orbital flow defines an orbital downstream direction,

wherein the circular guide portion is positioned centrally on the circular sieve screen and defines a central loading area of the sieve screen,

wherein the circular guide portion comprises a first radial opening extending in an upstream orbital direction from a first to a second side, and

wherein the upstream orbital direction is opposite a downstream orbital direction, and

(b) a lateral guide portion adapted to guide a lateral guided flow of granules from the central loading area of the sieve screen,

wherein the lateral guide portion comprises a first lateral guide member extending in a lateral direction from the first side of the first radial opening and to a periphery of the sieve screen;

wherein the sieve guide assembly is adapted to be mounted in a fractionating device in a specific angular position with the first lateral guide member aligned with a first side of an outlet of the fractionating device; and

wherein when the sieve guide assembly is mounted in the specific angular position in the fractionating device and when the fractionating device induces an orbital and a lateral flow, the lateral guided flow of the granules is guided along the first lateral guide member to the outlet.

2. The sieve guide assembly according to claim 1 , wherein the first lateral guide member is curved.

3. The sieve guide assembly according to claim 1 , further comprising a second lateral guide member extending in the lateral direction from the second side of the first radial opening.

4. The sieve guide assembly according to claim 3 , wherein the second lateral guide member is curved.

5. The sieve guide assembly according to claim 1 , wherein the sieve guide assembly comprises a key or a key-hole adapted to ensure the sieve guide assembly is mounted in the specific angular position.

6. The sieve guide assembly according to claim 1 , wherein the sieve guide assembly is adapted to be angularly adjustable, and wherein the sieve guide further is adapted to be fixed or clamped at the specific angular position.

7. A sieve guide assembly, comprising:

a circular sieve screen and a sieve guide;

wherein the sieve guide is fixedly attached to the sieve screen,

wherein the sieve guide comprises:

(a) a circular guide portion comprising a first radial opening extending from a first to a second side wherein the circular portion is positioned centrally on the circular sieve screen and defines a central loading area of the sieve screen for granules to be fractionated,

(b) a lateral guide portion comprising (i) a first lateral guide member extending from a first side of the first radial opening to a periphery of the sieve screen, and (ii) a second lateral guide member extending from a second side of the first radial opening towards the periphery;

wherein when the sieve guide assembly is mounted in a fractionating device and when the fractionating device induces an orbital and a lateral flow, the lateral guided flow of the granules are guided along the first and second lateral guide members.

8. A fractionating device adapted to fractionate granules for solid dosage forms, comprising: (a) the sieve guide assembly according to claim 1 or claim 7 , and (b) a tubular rim portion adapted to receive the sieve guide assembly,

wherein the tubular rim portion comprises an outlet;

wherein the outlet comprises an opening in the tubular rim portion extending in the upstream orbital direction from a first to a second side.

9. A fractionating device adapted to fractionate granules, comprising:

(a) a sieve deck comprising an inlet and a tubular rim portion comprising an outlet, wherein the outlet comprises an opening extending from a first to a second side, and

(b) a sieve screen and a sieve guide received in the sieve deck, wherein the sieve guide is fixedly attached to the sieve screen;

wherein the sieve guide comprises:

(i) a circular guide portion comprising a first radial opening extending from a first to a second side, wherein the circular guide portion is positioned centrally on the sieve screen and defines a central loading area of the sieve screen adapted to receive granules through the inlet, and

(ii) a lateral guide portion comprising a first guide member extending from the first side of the first radial opening to a periphery of the sieve screen;

wherein the outlet of the sieve deck comprises an opening extending from a first to a second side;

wherein the sieve guide is arranged in a specific angular position with the first lateral guide member aligned with the first side of the outlet of the sieve deck;

wherein the first radial opening is arranged with an angular overlap with the outlet; and

wherein when the fractionating device induces an orbital and a lateral flow, the granules are guided along the first lateral guide member to the outlet.

10. The fractionating device according to claim 9 , wherein the first lateral guide member is curved.

11. The fractionating device according to claim 9 , further comprising a second lateral guide member extending in the lateral direction from the second side of the first radial opening.

12. A method of fractionating granules for solid dosage forms comprising;

a) loading the granules to be fractionated onto the central loading area of the screen of the fractionating device according to claim 8 ,

b) fractionating the granules; and

c) collecting the fractionated granules at the outlet.

13. A method of producing a solid dosage form comprising;

a) obtaining granules comprising a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid (NAC);

b) fractionating the granules using the fractionation device according to claim 8 and

c) preparing the solid dosage form using the fractionated granules.

14. The method according to claim 13 , wherein the solid dosage form comprises one or more pharmaceutical active ingredients and optionally one or more pharmaceutically acceptable excipients.

15. The fractionating device according to claim 11 , wherein the second lateral guide member is curved.

16. The method according to claim 12 , wherein the solid dosage form is selected from the group consisting of a tablet, capsule, and sachet.

17. The method according to claim 13 , wherein the solid dosage form is selected from the group consisting of a tablet, capsule, and sachet.

18. The method according to claim 14 , wherein the solid dosage form is selected from the group consisting of a tablet, capsule, and sachet.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2022
From: VILHELMSEN, THOMAS; HOEEG-MOELLER, CARSTEN; SOERENSEN, MARTIN NOBERT; GAUNOE, METTE HOEG
To: NOVO NORDISK A/S
Reel/Frame 060896/0480 →
Priority Claims (1)
EP 19195783 · Sep 6, 2019 · regional
Continuity (1)
Related Publication 20220323360A1 · Oct 13, 2022
References Cited (21)
US 2029848A · Wettlaufer · 1936 [cited by examiner]
US 3206029A · Hurst · 1965 [cited by examiner]
US 3932442A · Salmon et al. · 1976 [cited by applicant]
US 4613432A · Racine et al. · 1986 [cited by applicant]
US 6623756B1 · Wilber et al. · 2003 [cited by applicant]
US 10086047B2 · Sauerberg et al. · 2018 [cited by applicant]
US 20110220745A1 · Politi et al. · 2011 [cited by applicant]
US 20130327685A1 · Kodama · 2013 [cited by examiner]
CN 1720109A · 2006 [cited by examiner]
CN 205146673U · 2016 [cited by applicant]
CN 105964535A · 2016 [cited by applicant]
CN 108883073A · 2018 [cited by applicant]
FR 1238009A · 1960 [cited by applicant]
JP 2005324170A · 2005 [cited by applicant]
JP 2016117759A · 2016 [cited by applicant]
WO 9911261A1 · 1999 [cited by applicant]
WO WO2004050263A1 · 2004 [cited by examiner]
WO WO2005049229A2 · 2005 [cited by examiner]
WO WO2006092727A2 · 2006 [cited by examiner]
WO WO2008056021A2 · 2008 [cited by examiner]
WO 2019149880A1 · 2019 [cited by applicant]